Uram, Ł.; Twardowska, M.; Szymaszek, Ż.; Misiorek, M.; Łyskowski, A.; Setkowicz, Z.; Rauk, Z.; Wołowiec, S.
The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer. Molecules 2024, 29, 4293.
https://doi.org/10.3390/molecules29184293
AMA Style
Uram Ł, Twardowska M, Szymaszek Ż, Misiorek M, Łyskowski A, Setkowicz Z, Rauk Z, Wołowiec S.
The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer. Molecules. 2024; 29(18):4293.
https://doi.org/10.3390/molecules29184293
Chicago/Turabian Style
Uram, Łukasz, Magdalena Twardowska, Żaneta Szymaszek, Maria Misiorek, Andrzej Łyskowski, Zuzanna Setkowicz, Zuzanna Rauk, and Stanisław Wołowiec.
2024. "The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer" Molecules 29, no. 18: 4293.
https://doi.org/10.3390/molecules29184293
APA Style
Uram, Ł., Twardowska, M., Szymaszek, Ż., Misiorek, M., Łyskowski, A., Setkowicz, Z., Rauk, Z., & Wołowiec, S.
(2024). The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer. Molecules, 29(18), 4293.
https://doi.org/10.3390/molecules29184293